Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 681 results for "cadila pharmaceutical"

Pharmaceuticals Newsletter - January 16 to 20, 2017
India Infoline

Pharmaceuticals Newsletter - January 16 to 20, 2017

Top News Zydus settles patent litigation with Kowa Cadila Healthcare Limited, a global pharmaceutical company and its subsidiary, Zydus Pharmaceuticals has announced an agreement with Kowa Company Limited, Kowa Pharmaceuticals America, and ... India Infoline, 2 days ago
CADILA SETTLES PATENT DISPUTE Pharmacy Choice, 2 days ago

20 images for cadila pharmaceutical

India Infoline, 2 days ago
India Infoline, 2 days ago
Money Control, 5 days ago
Odisha Television, 1 week ago
DealStreetAsia, 1 day ago
Financial Express, 1 month ago
DealStreetAsia, 3 weeks ago, 1 month ago
International Business Times India, 1 month ago
Money Control, 2 months ago

Zydus acquires Sentnyl, a US specialty pharma company

A leading global healthcare company, Zydus Cadila on January 19, announced that ithas acquired Sentnyl Therapeutics Inc., which is a US based specialty in the pharmaceutical business.
 India Infoline2 days ago Zydus Cadila acquires Sentynl Therapeutics, a US based specialty pharmaceutical company  FirstWord Pharma3 days ago Cadila Healthcare buys US-based Sentynl Therapeutics  Livemint.com2 days ago Zydus Cadila acquires California-based Sentynl Therapeutics  The American Bazaar2 days ago

Zydus Cadila receives US FDA marketing nod for methotrexate tablets

Zydus Cadila, a Rs. 9,400 crore plus pharma giant from Ahmedabad, has received the final approval from the US Food and Drug Administration (FDA) to market methotrexate tablets USP, 2.5 mg, a chemotherapy drug used for leukaemias, lymphomas, breast ...
 PharmaBiz3 days ago Zydus receives final approval from the USFDA for Methotrexate Tablets USP  FirstWord Pharma4 days ago

Sun Pharma, Dr Reddy's and Cadila under pressure after Donald Trump's press conference

NEW DELHI: Shares of pharmaceutical companies were reeling under pressure in early trade on Thursday following criticism by Donald Trump. The President-elect in a conference on Wednesday said pharmaceutical companies are "getting away with murder" ...
 Economic Times1 week ago Markets hold gains; pharma stocks under pressure on Trump speech  Smart Investor1 week ago

Pharma falls on Trump's comments, analysts say impact unlikely

Shares of Sun Pharma, Dr Reddy's Labs and Cadila were down dragging the index almost 1 percent from previous close. Major Indian pharma companies earn around 15-50 percent revenue from the US market. Shares of pharma companies were under pressure ...
 Moneycontrol.com1 week ago Pharma cos need to realign biz models  Express Pharma2 weeks ago Sun Pharma shares trail Sensex first time in seven years  Livemint.com4 weeks ago Nifty Pharmaceuticals Index Feels The Heat In 2016  Bloomberg-Quint1 month ago
International Business Times India

Indian pharma companies improved credibility in 2016: Nomura

Import and warning letters issued by the US FDA dropped in 2016 when compared to 2015; Sun Pharma, Cadila, Aurobindo, Divi, Lupin, Cipla, Alkem are top Indian drugmakers. People walk past a chemist shop at a market in Mumbai, India, June 25, 2015 ...
 International Business Times India3 weeks ago How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the US  Economic Times2 weeks ago Vietnam blacklists 39 Indian drug firms  CPhI.cn1 month ago Vietnam bans 39 Indian drug firms  Economic Times1 month ago
Sunday Guardian Live

Pankaj Patel of Zydus Cadila to replace Neotia as FICCI President

Share Tweet Share Share Share Pankaj Patel, CMD of leading pharmaceutical company Zydus Cadila, has been elected President of the Federation of Indian Chambers of Commerce and Industry (FICCI) for 2017, replacing ...
 EHealth Magazine2 months ago FICCI announces Pankaj Patel as the new President  Topnews.in1 month ago Pankaj Patel becomes National PresidentElect of FICCI  DeshGujarat2 months ago Zydus Cadila's CMD Pankaj Patel elected the president of FICCI  India Infoline2 months ago

Zydus recalls over 16k bottles of anti-depressant drug in US

Zydus Pharmaceuticals USA Inc is the US arm of Zydus Cadila's listed entity Cadila Healthcare
 Business Standard3 weeks ago Zydus recalls over 16,000 bottles of anti-depressant drug in US  Livemint.com3 weeks ago Sun Pharma, Cadila Healthcare recall products from US market  Livemint.com1 month ago
Financial Express

Three Made in India drugs recalled in US for not meet manufacturing norms: FDA

NEW DELHI: Three different drugs made in India, including by Cadila Pharma and Alkem Laboratories, are being recalled in the US for not meeting the manufacturing norms. According to the latest Enforcement Report of the USFDA, Cadila ...
 New Indian Express1 month ago
Pocket News

Gujarat based firm launches first indigenously developed seasonal influenza vaccine

Ahmedabad: Ahmedabad based CPL Biologicals Pvt. Ltd, a joint-venture biotechnology company of Cadila Pharmaceuticals Ltd, India and Novavax Inc., USA, has become the first Indian company to indigenously develop a vaccine for Seasonal Influenza, ...
 DeshGujarat2 months ago Cadila develops India's first virus like particle vaccine for treating flu  Smart Investor2 months ago Cadila Pharmaceuticals Develops India's First Virus Like Particle Vaccine For Treating Flu  Biotechin.Asia2 months ago CPL Biologicals launches Cadiflu-S - world's first VLP vaccine for seasonal influenza  PharmaBiz2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less